Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_assertion type Assertion NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_head.
- NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_assertion description "[Recently, a cirrhosis risk score (CRS) based on seven single-nucleotide polymorphisms was proposed as genetic predictor of cirrhosis in hepatitis C. To assess the role of CRS in predicting fibrosis progression in patients with initially no or minimal to moderate fibrosis, we investigated 271 untreated patients with chronic hepatitis C having initial liver biopsy showing METAVIR stage F0 (n = 104), F1 (n = 101), or F2 (n = 59) who had been followed up without antiviral therapies for at least 60 months (mean 108.5 +/- 71.5 months) and had a liver biopsy at the end of this observation period.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_provenance.
- NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_assertion evidence source_evidence_literature NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_provenance.
- NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_assertion SIO_000772 19676127 NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_provenance.
- NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_assertion wasDerivedFrom befree-20140225 NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_provenance.
- NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_assertion wasGeneratedBy ECO_0000203 NP382380.RAvI2EbAGCGtSMNlxF96YTlUQ6cAiOib3V2ZHCNN0LqL0130_provenance.